Shattuck Labs to Present Virtually at Evercore ISI 3rd Annual HealthCONx Conference

AUSTIN, TX and DURHAM, NC, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced it will participate in the Evercore ISI 3rd Annual HealthCONx conference being held December 1-3, 2020.

See the original post here:
Shattuck Labs to Present Virtually at Evercore ISI 3rd Annual HealthCONx Conference

Related Post